Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Bosso

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
American Journal of Pharmaceutical Education|December 24, 2010
Benchmarking in academic pharmacy departmentsJohn A Bosso, Marie Chisholm-Burns, Jean Nappi, et al.
Pharmacotherapy|July 31, 2013
Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitalsSusan L Davis, Marc H Scheetz, John A Bosso, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2009
Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteriaPatrick D Mauldin, Cassandra D Salgado, Ida Solhøj Hansen, et al.
Pharmacotherapy|September 5, 2017
Intravenous-only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae-Associated Bacteremic Urinary Tract InfectionKrista L Rieger, John A Bosso, Shawn H MacVane, et al.
Diagnostic Microbiology and Infectious Disease|July 11, 2002
Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000Roger L White, Kevin A Enzweiler, Lawrence V Friedrich, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2011
Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trialJohn A Bosso, Jean Nappi, Celeste Rudisill, et al.
Open Forum Infectious Diseases|July 27, 2018
In Vitro Activity of Ceftolozane/Tazobactam vs Nonfermenting, Gram-Negative Cystic Fibrosis IsolatesJeanne B Forrester, Lisa L Steed, Barbara A Santevecchi, et al.
Pharmacotherapy|May 27, 2015
Impact of a Stewardship-Initiated Restriction on Empirical Use of Ciprofloxacin on Nonsusceptibility of Escherichia coli Urinary Isolates to CiprofloxacinKristen A O'Brien, Jingwen Zhang, Patrick D Mauldin, et al.
American Journal of Pharmaceutical Education|August 25, 2012
AACP strategy for addressing the professional development needs of department chairsTerry L Schwinghammer, Tobias E Rodriguez, George Weinstein, et al.
Pharmacotherapy|March 28, 2009
Recommendations for training and certification for pharmacists practicing, mentoring, and educating in infectious diseases pharmacotherapyErika J Ernst, Michael E Klepser, John A Bosso, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
American Journal of Pharmaceutical Education|December 24, 2010
Benchmarking in academic pharmacy departmentsJohn A Bosso, Marie Chisholm-Burns, Jean Nappi, et al.
Pharmacotherapy|July 31, 2013
Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitalsSusan L Davis, Marc H Scheetz, John A Bosso, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2009
Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteriaPatrick D Mauldin, Cassandra D Salgado, Ida Solhøj Hansen, et al.
Pharmacotherapy|September 5, 2017
Intravenous-only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae-Associated Bacteremic Urinary Tract InfectionKrista L Rieger, John A Bosso, Shawn H MacVane, et al.
Diagnostic Microbiology and Infectious Disease|July 11, 2002
Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000Roger L White, Kevin A Enzweiler, Lawrence V Friedrich, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2011
Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trialJohn A Bosso, Jean Nappi, Celeste Rudisill, et al.
Open Forum Infectious Diseases|July 27, 2018
In Vitro Activity of Ceftolozane/Tazobactam vs Nonfermenting, Gram-Negative Cystic Fibrosis IsolatesJeanne B Forrester, Lisa L Steed, Barbara A Santevecchi, et al.
Pharmacotherapy|May 27, 2015
Impact of a Stewardship-Initiated Restriction on Empirical Use of Ciprofloxacin on Nonsusceptibility of Escherichia coli Urinary Isolates to CiprofloxacinKristen A O'Brien, Jingwen Zhang, Patrick D Mauldin, et al.
American Journal of Pharmaceutical Education|August 25, 2012
AACP strategy for addressing the professional development needs of department chairsTerry L Schwinghammer, Tobias E Rodriguez, George Weinstein, et al.
Pharmacotherapy|March 28, 2009
Recommendations for training and certification for pharmacists practicing, mentoring, and educating in infectious diseases pharmacotherapyErika J Ernst, Michael E Klepser, John A Bosso, et al.
Pageof 4